Infergen and Hydrochlorothiazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Infergen (interferon alfacon-1) and Hydrochlorothiazide (hydrochlorothiazide). Common drug interactions include sleep walking among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Infergen and Hydrochlorothiazide. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Infergen?

Infergen has active ingredients of interferon alfacon-1. eHealthMe is studying from 766 Infergen users. Check the latest studies of Infergen.

What is Hydrochlorothiazide?

Hydrochlorothiazide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 182,194 Hydrochlorothiazide users. Check the latest studies of Hydrochlorothiazide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

31 people who take Infergen and Hydrochlorothiazide together, and have interactions are studied.

Infergen and Hydrochlorothiazide drug interactions.

What are the common drug interactions of Infergen and Hydrochlorothiazide, by gender? *:

female:

Sleep walking (walking during sleep)
Speech disorder
Syncope (loss of consciousness with an inability to maintain postural tone)
Vision blurred
Visual disturbance
Weight increased
White blood cell count decreased
Headache (pain in head)
Dizziness
Pain

male:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Constipation
Decreased appetite
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dyspnoea (difficult or laboured respiration)
Hypokalaemia (low potassium)
Injection site haematoma (localized swelling filled with blood at injection site)
Memory impairment
Pruritus (severe itching of the skin)

What are the common drug interactions of Infergen and Hydrochlorothiazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Drug toxicity
Hyperuricaemia (level of uric acid in the blood that is abnormally high)

40-49:

Dysgeusia (disorder of the sense of taste)
Fatigue (feeling of tiredness)
Hydrocephalus (water on the brain)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Arthralgia (joint pain)
Asthenia (weakness)
Chest pain
Constipation
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dysuria (painful or difficult urination)

50-59:

Decreased appetite
Hypokalaemia (low potassium)
Injection site haematoma (localized swelling filled with blood at injection site)
Malaise (a feeling of general discomfort or uneasiness)
Red blood cell count decreased
Thrombocytopenia (decrease of platelets in blood)
Upper respiratory tract infection
Abasia (inability to walk)
Activities of daily living impaired
Alanine aminotransferase increased

60+:

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Petit mal epilepsy (absence seizure)

What are the existing conditions these people have? *

Hepatitis C: 22 people, 70.97%

* Approximation only. Some reports may have incomplete information.

Do you take Infergen and Hydrochlorothiazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously